Cyclodextrin-based polymers for therapeutics delivery
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 12, 2013
Issued Date -
N/A
app pub date -
Feb 15, 2013
filing date -
Sep 6, 2002
priority date (Note) -
In Force
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance

US Family Size
|
Non-US Coverage
|
Patent Longevity
|
Forward Citations
|
Abstract
The present invention relates to novel compositions of therapeutic cyclodextrin containing polymeric compounds designed as a carrier for small molecule therapeutics delivery and pharmaceutical compositions thereof. These cyclodextrin-containing polymers improve drug stability and solubility, and reduce toxicity of the small molecule therapeutic when used in vivo. Furthermore, by selecting from a variety of linker groups and targeting ligands the polymers present methods for controlled delivery of the therapeutic agents. The invention also relates to methods of treating subjects with the therapeutic compositions described herein. The invention further relates to methods for conducting pharmaceutical business comprising manufacturing, licensing, or distributing kits containing or relating to the polymeric compounds described herein.
First Claim
all claims..Other Claims data not available
Family

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
CERULEAN PHARMA INC | 161 FIRST STREET CAMBRIDGE MA 02142 |
International Classification(s)

- 2013 Application Filing Year
- A61K Class
- 12711 Applications Filed
- 11051 Patents Issued To-Date
- 86.95 % Issued To-Date
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Cheng, Jianjun | Arcadia, US | 72 | 1305 |
# of filed Patents : 72 Total Citations : 1305 | |||
Davis, Mark E | Pasadena, US | 255 | 5536 |
# of filed Patents : 255 Total Citations : 5536 | |||
Khin, Kay T | San Gabriel, US | 20 | 261 |
# of filed Patents : 20 Total Citations : 261 |
Cited Art Landscape
- No Cited Art to Display

Patent Citation Ranking
- 3 Citation Count
- A61K Class
- 14.18 % this patent is cited more than
- 12 Age
Forward Cite Landscape
- No Forward Cites to Display

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|---|---|---|---|
11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | May 12, 2025 |
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge - 11.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text

Legal Events
Date | Code | Event | Description |
---|---|---|---|
Jun 30, 2025 | FEPP | FEE PAYMENT PROCEDURE | free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
Apr 28, 2021 | MAFP | MAINTENANCE FEE PAYMENT | free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY year of fee payment: 8 |
Dec 08, 2017 | FEPP | FEE PAYMENT PROCEDURE | free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.) |
May 12, 2017 | FPAY | FEE PAYMENT | year of fee payment: 4 |
Jul 29, 2014 | CC | CERTIFICATE OF CORRECTION | |
Nov 12, 2013 | I | Issuance | |
Oct 23, 2013 | STCF | INFORMATION ON STATUS: PATENT GRANT | free format text: PATENTED CASE |
Aug 08, 2013 | P | Published | |
Feb 15, 2013 | F | Filing | |
Jun 23, 2009 | AS | ASSIGNMENT | free format text: MERGER;ASSIGNOR:INSERT THERAPEUTICS, INC.;REEL/FRAME:030064/0600 Owner name: CALANDO PHARMACEUTICALS INC., CALIFORNIA Effective Date: Apr 17, 2008 free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CHENG, JIANJUN;DAVIS, MARK E.;KHIN, KAY T.;REEL/FRAME:030064/0589 Owner name: INSERT THERAPEUTICS, INC., CALIFORNIA Effective Date: Sep 30, 2003 free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CALANDO PHARMACEUTICALS, INC.;REEL/FRAME:030064/0628 Owner name: CERULEAN PHARMA INC., MASSACHUSETTS Effective Date: Jun 23, 2009 |
Sep 06, 2002 | PD | Priority Date |

Matter Detail

Renewals Detail
